Mostrando 3 resultados de: 3
Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC
ArticleAbstract: Hepatocellular carcinoma (HCC) has very poor prognosis. Astemizole has gained great interest as a poPalabras claves:Astemizole, Eag1, Liver cancer, Liver cirrhosis, Potassium channels, tumor markersAutores:Acuña-Macías I., Caro-Sánchez C.H., Chiliquinga A.J., de Guadalupe Chávez-López M., Díaz-Chávez J., Gariglio P., Hernández-gallegos E., Herrera L.A., Javier Camacho, Pérez-Carreón J.I., Zúñiga-García V.Fuentes:scopusMicroRNAs in cervical cancer: Evidences of a miRNA de-regulation caused by HPV
Book PartAbstract: Cervical carcinoma (CC) is one of the most common cancers and a leading cause of mortality in womenPalabras claves:Autores:Alvarez-Gómez R., Arechaga-Ocampo E., Carlos Barba-Ostria, Fernández-Retana J., Herrera L.A., Jacobo-Herrera N., León D.C.D., López-Camarillo C., Peralta-Zaragoza O., Pérez-Plasencia C.Fuentes:googlescopusSomatic Mutational Landscape in Mexican Patients: CDH1 Mutations and chr20q13.33 Amplifications Are Associated with Diffuse-Type Gastric Adenocarcinoma
ArticleAbstract: The Hispanic population, compared with other ethnic groups, presents a more aggressive gastric cancePalabras claves:cancer genomics, copy number variation, Gastric Cancer, Hispanic ethnicity, Mutations, Precision MedicineAutores:Alonso-Larraga J.O., Basurto-Lozada P., Cantú-de-León D., Cerrato-Izaguirre D., Chirino Y.I., García-Cuellar C.M., Hernández-Guerrero A., Herrera L.A., Herrera-Goepfert R., Javier Camacho, Meneses-García A., Oñate-Ocaña L.F., Prada D., Quezada-Maldonado E.M., Robles-Espinoza C.D., Sánchez-Pérez Y.Fuentes:scopus